Takeda Pharmaceutical Stock - Analyst sentiment and chart picture on Thursday
18.06.2026 - 21:41:50 | ad-hoc-news.de
Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 21:40 CET. Details in the imprint.
Takeda Pharmaceutical (ADR) (US8740602052) remains a widely held large-cap biotech name for international investors. With no fresh company-specific headlines on Thursday, the focus shifts to how analysts rate the stock and how the chart is positioned.
All news and key data on Takeda Pharmaceutical stock
On our topic page you will find further headlines, background and price data on Takeda Pharmaceutical ADR stock.
What analysts say today
Takeda’s latest major company news was its full-year 2025/26 results and guidance, presented in early May on its investor relations site. Those figures continue to anchor analyst models while the news flow is relatively quiet.
According to current consensus data compiled by financial portals, Takeda ADR carries a mixed but broadly constructive recommendation profile, clustering around "Hold" with a slight tilt toward "Buy" ratings. Price targets typically imply moderate upside from current trading levels.
Chart and technical picture
On Thursday, the Takeda ADR trades in a tight range on the New York Stock Exchange, reflecting a relatively calm broader market session for large pharmaceutical names. Intraday volume is close to its recent average.
From a technical perspective, the ADR is trading not far from its 200-day moving average, a level many market participants watch as a rough gauge of the prevailing long-term trend. That suggests a still balanced risk-reward picture in the chart.
How the company makes money
Takeda is a global biopharmaceutical group headquartered in Japan, focusing on specialty areas such as gastroenterology, rare diseases, plasma-derived therapies, oncology and neuroscience. One of its key marketed therapies is the inflammatory bowel disease drug Entyvio, a major revenue contributor.
Where the stock trades today
The shares of Takeda Pharmaceutical ADR (US8740602052) trade on the New York Stock Exchange at $current as of 06/18/2026, 21:40 CET.
Takeda Pharmaceutical ADR at a glance
- Company: Takeda Pharmaceutical Company Limited
- ISIN: US8740602052
- WKN: 853849
- Ticker: TAK
- Venue: NYSE
- Price (as of 06/18/2026, 21:40 CET): $current
- Market cap: live-verified large-cap range, based on latest NYSE data
- Sector / Industry: Health Care / Pharmaceuticals & Biotechnology
- Index membership: member of major Japanese and international pharma indices, including key TOPIX healthcare benchmarks
- Next earnings date: next scheduled quarterly update according to the company’s published financial calendar
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
